GLTO Galecto Inc

USD 0.67 0.00 -0.312966
Icon

Galecto Inc (GLTO) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.6689000000000001

0.00 (-0.31)%

USD 0.02B

0.03M

N/A

N/A

Icon

GLTO

Galecto Inc (USD)
COMMON STOCK | NSD
USD 0.67
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 0.67

Galecto Inc (GLTO) Stock Forecast

N/A

Based on the Galecto Inc stock forecast from 0 analysts, the average analyst target price for Galecto Inc is not available over the next 12 months. Galecto Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Galecto Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Galecto Inc’s stock price was USD 0.6689000000000001. Galecto Inc’s stock price has changed by -7.10% over the past week, -9.82% over the past month and -64.98% over the last year.

No recent analyst target price found for Galecto Inc
No recent average analyst rating found for Galecto Inc

Company Overview Galecto Inc

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB...Read More

https://galecto.com

Ole Maaloes Vej 3, Copenhagen, Denmark, 2200

13

December

USD

USA

Adjusted Closing Price for Galecto Inc (GLTO)

Loading...

Unadjusted Closing Price for Galecto Inc (GLTO)

Loading...

Share Trading Volume for Galecto Inc Shares

Loading...

Compare Performance of Galecto Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GLTO

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Galecto Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -3.06 (-0.76%) USD107.38B 29.93 21.06

ETFs Containing GLTO

Symbol Name GLTO's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Galecto Inc (GLTO) Stock

Stock Target Advisor's fundamental analysis for Galecto Inc's stock is Bearish.

Unfortunately we do not have enough data on GLTO's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on GLTO's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on GLTO's stock to indicate if its overvalued.

The last closing price of GLTO's stock was USD 0.67.

The most recent market capitalization for GLTO is USD 0.02B.

Unfortunately we do not have enough analyst data on GLTO's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Galecto Inc's stock.

As per our most recent records Galecto Inc has 13 Employees.

Galecto Inc's registered address is Ole Maaloes Vej 3, Copenhagen, Denmark, 2200. You can get more information about it from Galecto Inc's website at https://galecto.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...